EFFECTIVE DOSE ESTIMATION FROM ORGAN DOSE MEASUREMENTS IN FAST-kV SWITCH DUAL ENERGY COMPUTED TOMOGRAPHY.

The purpose of this study was to validate a novel approach to estimating effective dose (E) in 'fast-kV switch dual energy computed tomography' using MOSFET detectors. The effective energy of the combined dual energy environment was characterized with the dual energy CT scanner and then MOSFETs were calibrated matching to the effective energy of the dual energy CT beam with a conventional CT beam. The calibration method was then experimentally validated by comparing the dose between MOSFET and an ion chamber (IC) using a standard CTDI body phantom. The measured doses of the MOSFET and IC were 17.1 mGy ± 3.8% and 17.1 mGy ± 0.4%, respectively. To measure organ doses, an adult anthropomorphic phantom loaded with 18 MOSFET detectors was scanned using a standard fast-kV switch dual energy abdomen/pelvis CT protocol. E was calculated by applying ICRP 103 tissue weighting factors as well as partial volume correction factors for organs that were not completely covered by the protocol field-of-view. E from the dual energy abdomen/pelvis CT was calculated to be 17.8 mSv ± 11.6%. This calculation was then compared to E from dose length product method, which yielded 14.62 mSv.

Evaluating Lens Dose Reduction in Pediatric Neuroradiology Examinations Using Automated Kilovoltage Selection Software.

OBJECTIVE: The purpose of this study is to evaluate the potential of an automated kilo-voltage selection software for the reduction of lens dose in pediatric CT scans. MATERIALS AND METHODS: Two metal oxide semiconductor field effect transistor (MOSFET) detectors measured the lens dose in two anthropomorphic 1- and 5-year-old phantoms. These phantoms were scanned using a clinical pediatric brain protocol at 120 kVp as a control with the MDCT scanner. Scans were then repeated using automated kilovoltage software. The automated kilovoltage was set to operate at tube potentials of 120, 110, and 100 kVp. Dose savings were compared with the average lens dose of both eyes between automated kilovoltage and the control setting. Image quality was studied by contrast-to-noise ratios (CNRs) for each setting. RESULTS: The mean (± SD) lens dose from the routine brain scan without automated kilovoltage was 0.92 ± 0.03 cGy and 0.81 ± 0.03 cGy for the 1- and 5-year-old phantoms, respectively. Use of the automated kilovoltage software at 120 kVp, 110 kVp, and 100 kVp resulted in dose reductions of 9.8%, 17.4%, and 19.6%, respectively, for the 1-year-old phantom and 1.2%, 8.6%, and 17.3%, respectively, for the 5-year-old phantom. The CNR for all automated kilovoltage scans was within 11% of the control scans for the 1-year-old and within 6% for the 5-year-old phantom. CONCLUSION: Our results show that automated kilovoltage software is effective for reducing the radiation dose to the lens of the eye in pediatric patients. Furthermore, the image quality by CNR remained acceptable within 11% of the baseline for all kilovoltage settings used.

Impact of imaging approach on radiation dose and associated cancer risk in children undergoing cardiac catheterization.

OBJECTIVES: To quantify the impact of image optimization on absorbed radiation dose and associated risk in children undergoing cardiac catheterization. BACKGROUND: Various imaging and fluoroscopy system technical parameters including camera magnification, source-to-image distance, collimation, antiscatter grids, beam quality, and pulse rates, all affect radiation dose but have not been well studied in younger children. METHODS: We used anthropomorphic phantoms (ages: newborn and 5 years old) to measure surface radiation exposure from various imaging approaches and estimated absorbed organ doses and effective doses (ED) using Monte Carlo simulations. Models developed in the National Academies' Biological Effects of Ionizing Radiation VII report were used to compare an imaging protocol optimized for dose reduction versus suboptimal imaging (+20 cm source-to-image-distance, +1 magnification setting, no collimation) on lifetime attributable risk (LAR) of cancer. RESULTS: For the newborn and 5-year-old phantoms, respectively ED changes were as follows: +157% and +232% for an increase from 6-inch to 10-inch camera magnification; +61% and +59% for a 20 cm increase in source-to-image-distance; -42% and -48% with addition of 1-inch periphery collimation; -31% and -46% with removal of the antiscatter grid. Compared with an optimized protocol, suboptimal imaging increased ED by 2.75-fold (newborn) and fourfold (5 years old). Estimated cancer LAR from 30-min of posteroanterior fluoroscopy using optimized versus suboptimal imaging, respectively was 0.42% versus 1.23% (newborn female), 0.20% versus 0.53% (newborn male), 0.47% versus 1.70% (5-year-old female) and 0.16% versus 0.69% (5-year-old male). CONCLUSIONS: Radiation-related risks to children undergoing cardiac catheterization can be substantial but are markedly reduced with an optimized imaging approach. © 2016 Wiley Periodicals, Inc.

A NOVEL APPROACH FOR EFFECTIVE DOSE MEASUREMENTS IN DUAL-ENERGY CT.

A novel method was presented for the effective dose (ED) measurement with metal-oxide-semiconductor field-effect transistor (MOSFET) detectors in dual-energy (DE) dual-source (DS) computed tomography (CT) scanner. This study demonstrated that the mean energy of the combined spectrum in dual-source computed tomography can be used to measure the ED. For validation, the MOSFET dose at the centre cavity of a CT dose index (CTDI) body phantom was compared with the dose measured with an energy-independent ion chamber (IC). A clinical abdomen/pelvis scan was performed with an adult anthropomorphic phantom, and ED was compared between the MOSFET method and the dose length product (DLP) method. The tissue doses in the CTDI phantom were 2.08±(2.70 %) with IC and 2.20±(4.82 %) cGy with MOSFET; the per cent difference was 5.91 %, and the t-test showed that there was no statistically significant difference. EDs for the abdomen/pelvis scans were 5.01±(2.34 %) mSv with MOSFET and 5.56 mSv with the DLP method.

Feasibility of using the computed tomography dose indices to estimate radiation dose to partially and fully irradiated brains in pediatric neuroradiology examinations.

The purpose of this study was two-fold: (a) to measure the dose to the brain using clinical protocols at our institution, and (b) to develop a scanner-independent dosimetry method to estimate brain dose. Radiation dose was measured with a pediatric anthropomorphic phantom and MOSFET detectors. Six current neuroradiology protocols were used: brain, sinuses, facial bones, orbits, temporal bones, and craniofacial areas. Two different CT vendor scanners (scanner A and B) were used. Partial volume correction factors (PVCFs) were determined for the brain to account for differences between point doses measured by the MOSFETs and average organ dose. The CTDIvol and DLP for each protocol were recorded. The dose to the brain (mGy) for scanners A and B was 10.7 and 10.0 for the brain protocol, 7.8 and 3.2 for the sinus, 10.2 and 8.6 for the facial bones, 7.4 and 4.7 for the orbits and 1.6 and 1.9 for the temporal bones, respectively. On scanner A, the craniofacial protocol included a standard and high dose option; the dose measured for these exams was 3.9 and 16.9 mGy, respectively. There was only one craniofacial protocol on scanner B; the brain dose measured on this exam was 4.8 mGy. A linear correlation was found between DLP and brain dose with the conversion factors: 0.049 (R(2) = 0.87), 0.046 (R(2) = 0.89) for scanner A and B, and 0.048 (R(2) = 0.89) for both scanners. The range of dose observed was between 1.8 and 16.9 mGy per scan. This suggests that brain dose estimates may be made from DLP.

Lifetime Attributable Risk of Cancer From Radiation Exposure During Parathyroid Imaging: Comparison of 4D CT and Parathyroid Scintigraphy.

OBJECTIVE: The purpose of this study is to measure the organ doses and effective dose (ED) for parathyroid 4D CT and scintigraphy and to estimate the lifetime attributable risk of cancer incidence associated with imaging. MATERIALS AND METHODS: Organ radiation doses for 4D CT and scintigraphy were measured on the basis of imaging with our institution's protocols. An anthropomorphic phantom with metal oxide semiconductor field effect transistor detectors was scanned to measure CT organ dose. Organ doses from the radionuclide were based on International Commission for Radiological Protection report 80. ED was calculated for 4D CT and scintigraphy and was used to estimate the lifetime attributable risk of cancer incidence for patients differing in age and sex with the approach established by the Biologic Effects of Ionizing Radiation VII report. A 55-year-old woman was selected as the standard patient according to the demographics of patients with primary hyperparathyroidism. RESULTS: Organs receiving the highest radiation dose from 4D CT were the thyroid (150.6 mGy) and salivary glands (137.8 mGy). For scintigraphy, the highest organ doses were to the colon (41.5 mGy), gallbladder (39.8 mGy), and kidneys (32.3 mGy). The ED was 28 mSv for 4D CT, compared with 12 mSv for scintigraphy. In the exposed standard patient, the lifetime attributable risk for cancer incidence was 193 cancers/100,000 patients for 4D CT and 68 cancers/100,000 patients for scintigraphy. Given a baseline lifetime incidence of cancer of 46,300 cancers/100,000 patients, imaging results in an increase in lifetime incidence of cancer over baseline of 0.52% for 4D CT and 0.19% for scintigraphy. CONCLUSION: The ED of 4D CT is more than double that of scintigraphy, but both studies cause negligible increases in lifetime risk of cancer. Clinicians should not allow concern for radiation-induced cancer to influence decisions regarding workup in older patients.

A novel method of estimating effective dose from the point dose method: a case study--parathyroid CT scans.

The purpose of this study was to validate a novel approach of applying a partial volume correction factor (PVCF) using a limited number of MOSFET detectors in the effective dose (E) calculation. The results of the proposed PVCF method were compared to the results from both the point dose (PD) method and a commercial CT dose estimation software (CT-Expo). To measure organ doses, an adult female anthropomorphic phantom was loaded with 20 MOSFET detectors and was scanned using the non-contrast and 2 phase contrast-enhanced parathyroid imaging protocols on a 64-slice multi-detector computed tomography scanner. E was computed by three methods: the PD method, the PVCF method, and the CT-Expo method. The E (in mSv) for the PD method, the PVCF method, and CT-Expo method was 2.6  ±  0.2, 1.3  ±  0.1, and 1.1 for the non-contrast scan, 21.9  ±  0.4, 13.9  ±  0.2, and 14.6 for the 1st phase of the contrast-enhanced scan, and 15.5  ±  0.3, 9.8  ±  0.1, and 10.4 for the 2nd phase of the contrast-enhanced scan, respectively. The E with the PD method differed from the PVCF method by 66.7% for the non-contrast scan, by 44.9% and by 45.5% respectively for the 1st and 2nd phases of the contrast-enhanced scan. The E with PVCF was comparable to the results from the CT-Expo method with percent differences of 15.8%, 5.0%, and 6.3% for the non-contrast scan and the 1st and 2nd phases of the contrast-enhanced scan, respectively. To conclude, the PVCF method estimated E within 16% difference as compared to 50-70% in the PD method. In addition, the results demonstrate that E can be estimated accurately from a limited number of detectors.

Accuracy of effective dose estimation in personal dosimetry: a comparison between single-badge and double-badge methods and the MOSFET method.

The purpose of this study was three-fold: (1) to measure the transmission properties of various lead shielding materials, (2) to benchmark the accuracy of commercial film badge readings, and (3) to compare the accuracy of effective dose (ED) conversion factors (CF) of the U.S. Nuclear Regulatory Commission methods to the MOSFET method. The transmission properties of lead aprons and the accuracy of film badges were studied using an ion chamber and monitor. ED was determined using an adult male anthropomorphic phantom that was loaded with 20 diagnostic MOSFET detectors and scanned with a whole body CT protocol at 80, 100, and 120 kVp. One commercial film badge was placed at the collar and one at the waist. Individual organ doses and waist badge readings were corrected for lead apron attenuation. ED was computed using ICRP 103 tissue weighting factors, and ED CFs were calculated by taking the ratio of ED and badge reading. The measured single badge CFs were 0.01 (±14.9%), 0.02 (±9.49%), and 0.04 (±15.7%) for 80, 100, and 120 kVp, respectively. Current regulatory ED CF for the single badge method is 0.3; for the double-badge system, they are 0.04 (collar) and 1.5 (under lead apron at the waist). The double-badge system provides a better coefficient for the collar at 0.04; however, exposure readings under the apron are usually negligible to zero. Based on these findings, the authors recommend the use of ED CF of 0.01 for the single badge system from 80 kVp (effective energy 50.4 keV) data.

Digital tomosynthesis: a new technique for imaging nephrolithiasis. Specific organ doses and effective doses compared with renal stone protocol noncontrast computed tomography.

OBJECTIVE: To determine organ-specific doses (ODs) and effective dose (ED) for digital tomosynthesis (DT) and compare it with our institutional renal stone protocol noncontrast computed tomography (NCCT). METHODS: A validated anthropomorphic male phantom was placed supine on a digital GE Definium 8000 radiological scanner. Thermoluminescent dosimeters were placed in 256 locations and used to measure OD. A routine DT study was performed consisting of 2 scout images and 1 tomographic sweep in a 14.2-degree arc over the phantom. Software is used to recreate a series of coronal images from the sweep. ODs were determined as the sum of the doses for the study. Equivalent doses were calculated by multiplying OD with the appropriate tissue weighting factor. ED is the summation of the equivalent doses. OD and ED were determined in a similar fashion (using dosimeters) for a renal stone protocol NCCT and doses were compared. RESULTS: ODs for DT are significantly lower compared with NCCT. The ED for NCCT is 3.04 ± 0.34 mSv. The calculated ED for DT is 0.87 ± 0.15 mSv (2 scouts at 0.17 mSv and 0.14 mSv and 1 sweep at 0.56 mSv), P <.0001. CONCLUSION: DT exposes patients to substantially less radiation than NCCT. This is particularly true for radiation-sensitive organs. Further studies are needed to compare the sensitivity and specificity of DT as compared with NCCT. However, its low overall radiation dose makes it an ideal study for the follow-up of recurrent stone formers in the office setting.

Radiation exposure in the follow-up of patients with urolithiasis comparing digital tomosynthesis, non-contrast CT, standard KUB, and IVU.

OBJECTIVE: To compare the effective doses (EDs) associated with imaging modalities for follow-up of patients with urolithiasis, including stone protocol non-contrast computed tomography (NCCT), kidney, ureter, and bladder radiograph (KUB), intravenous urogram (IVU), and digital tomosynthesis (DT). METHODS: A validated Monte-Carlo simulation-based software PCXMC 2.0 (STUK) designed for estimation of patient dose from medical X-ray exposures was used to determine the ED for KUB, IVU (KUB scout plus three tomographic images), and DT (two scouts and one tomographic sweep). Simulations were performed using a two-dimensional stationary field onto the corresponding body area of the built-in digital phantom, with actual kVp, mAs, and geometrical parameters of the protocols. The ED for NCCT was determined using an anthropomorphic male phantom that was placed prone on a 64-slice GE Healthcare volume computed tomography (VCT) scanner. High-sensitivity metal oxide semiconductor field effect transistors dosimeters were placed at 20 organ locations and used to measure organ radiation doses. RESULTS: The ED for a stone protocol NCCT was 3.04±0.34 mSv. The ED for a KUB was 0.63 and 1.1 mSv for the additional tomographic film. The total ED for IVU was 3.93 mSv. The ED for DT performed with two scouts and one sweep (14.2°) was 0.83 mSv. CONCLUSIONS: Among the different imaging modalities for follow-up of patients with urolithiasis, DT was associated with the least radiation exposure (0.83 mSv). This ED corresponds to a fifth of NCCT or IVU studies. Further studies are needed to demonstrate the sensitivity and specificity of DT for the follow-up of nephrolithiasis patients.